Senior Regional Clinical Research Coordinator(Central & Eastern Europe) at Iterative Health

Europe

Iterative Health Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Clinical Research, Gastroenterology, HepatologyIndustries

Requirements

  • 5+ years as a Clinical Research Coordinator (senior level preferred) on Phase 2–4, pharma-sponsored trials; GI/IBD a plus
  • Strong ICH-GCP; confident coordinating patient journeys end-to-end
  • Hands-on with CTMS/eTMF and productivity tools (Google/Microsoft); Asana or similar PM tools
  • Trainer mindset: able to explain workflows simply and tailor by audience
  • Data-driven operator: baselines, KPIs, bottlenecks, actions, outcomes
  • Comfortable with ambiguity; excellent multi-project time management
  • ~20% travel

Responsibilities

  • Own multi-country study flow. Orchestrate day-to-day operations across sites from CDA/feasibility → CTR → start-up → SIV → activation → recruitment, keeping sites, CROs, and IH teams in lockstep
  • Speed up activation. Prepare SIVs, chase critical-path items, and drive ≤14-day activation post-SIV wherever feasible
  • Be the first-line site partner. Triage questions, unblock issues fast, and escalate crisply when decisions or resources are needed
  • Make documentation airtight. Collect/QC feasibility and start-up packages; keep trackers current (Asana/CTMS/eTMF) and audit for gaps before they become delays
  • Enable tool adoption. Train site teams on IH services/AI solutions; tailor job aids, checklists, and quick-hit workflows by role (PI, CRC, coordinator, admin)
  • Keep everyone in the loop. Run a simple, predictable cadence of updates with sites and internal teams; maintain clear decision logs and action owners
  • Track performance like a hawk. Monitor cycle times, SIV→activation, screen/enroll trends, and issue SLAs; spot bottlenecks early and course-correct
  • Continuously improve. Turn recurring pain points into lightweight fixes—templates, automation, small process tweaks—and share wins across the network
  • Cover the field. Travel as needed (~20%) for selection visits, SIVs, training, and issue resolution; represent IH standards consistently across countries

Skills

Clinical Research
Study Coordination
Site Management
CTMS
eTMF
Asana
SIV
Feasibility
Recruitment
CRO Management
AI Tools
Performance Tracking

Iterative Health

AI-driven solutions for gastrointestinal care

About Iterative Health

Iterative Health focuses on improving gastrointestinal (GI) care through the use of artificial intelligence (AI) and machine learning (ML). Their main product, SKOUT®, is an FDA-cleared device designed to help doctors detect adenomas, which are precursors to colorectal cancer. This device works alongside physician judgment to enhance the accuracy of diagnoses. In addition to SKOUT®, Iterative Health provides services that optimize clinical trials by using AI-enabled documentation technology, which improves patient care and ensures high-quality reporting across different healthcare institutions. This technology aims to make advanced care more accessible, especially to underserved populations. Unlike many competitors, Iterative Health combines AI technology with a strong focus on colorectal cancer prevention and clinical trial efficiency. The company's goal is to deliver top-tier GI care and improve health outcomes for patients worldwide.

Boston, MassachusettsHeadquarters
2017Year Founded
$182.1MTotal Funding
SERIES_BCompany Stage
AI & Machine Learning, HealthcareIndustries
51-200Employees

Benefits

Vision/Dental/ Medical Insurance
Life/Disability Insurance
Parental Leave
Stock Options
Flexible Work Hours
Unlimited Paid Time Off

Risks

Competition from tech giants in AI medical imaging threatens Iterative Health's market share.
Rapid expansion and partnerships may strain operational capabilities and resources.
Reliance on AI exposes Iterative Health to potential ethical and regulatory scrutiny.

Differentiation

Iterative Health uses AI to enhance GI care, focusing on colorectal cancer prevention.
Their SKOUT® device aids in adenoma detection, improving diagnostic accuracy in endoscopy.
AI-enabled documentation technology optimizes clinical trials, enhancing research quality and continuity.

Upsides

AI-driven predictive analytics in gastroenterology allow for personalized, effective patient care.
Partnerships with Gastro Health and One GI® expand clinical research capabilities in GI care.
$150M Series B funding accelerates AI innovations, transforming gastroenterology care.

Land your dream remote job 3x faster with AI